MMP2 and mesothelioma: It is possible that the mesothelioma study [29] did not achieve sufficient abrogation of β1 integrin to reduce MMP-2 activation at 48 hours after transfection integrin β1-targeting siRNA where β1 integrin is not complete knockdown.